U.S. Department of Health and Human Services Stocks Up On Radiation Drug Nplate As Putin Edges Closer To Launching Nuclear War

    0
    446

    by Geoffrey Grinder, Now The End Begins:

    As Putin threatens nuclear war, a $290 million procurement of the drug Nplate, to treat acute radiation syndrome (ARS), was announced by the US Health and Human Services (HSS).

    Yesterday we showed you how Ukraine is stocking up on drugs to treat radiation sickness, the kind you get when someone drops a nuclear bomb on you. Today we learn that the United states is also stocking up on radiation drug Nplate, hundreds of millions of dollars worth. Do you think the US thinks that Putin is bluffing, doesn’t look like it.

    TRUTH LIVES on at https://sgtreport.tv/

    “And this shall be the plague wherewith the LORD will smite all the people that have fought against Jerusalem; Their flesh shall consume away while they stand upon their feet, and their eyes shall consume away in their holes, and their tongue shall consume away in their mouth.” Zechariah 14:12 (KJB)

    Whether or not Putin will start dropping bombs on his perceived enemies remains to be seen, one thing is absolutely for certain. What we are watching is complete and total end times theater, where anything and everything is not only possible but probable. The United States has spent tens of billions of dollars fighting Russia by proxy through the Ukraine government itself set up back in 2014. Are the people who actually run the United States intentionally pushing Putin towards nuclear war. Now that’s a really good question.

    US splashes $290m on anti-radiation drugs after Putin ups nuclear threats

    FROM MSN: The government confirmed it was the first purchase of the drug, manufactured by the California pharmaceutical company Amgen. The purchase comes after Vladimir Putin renewed his threat of nuclear war. In a speech last month he vowed to use “all the means at our disposal” to protect Russia and its people. “This is not a bluff,” he said.

    The US government said the procurement of Nplate was not in response to the war in Ukraine.

    An HSS spokesman told The Telegraph: “This is part of our ongoing work for preparedness and radiological security. It has not been accelerated by the situation in Ukraine.” It is understood the HSS has been working with Amgen, and similar companies, for some years. The US has maintained a stockpile of Leukine, a drug which also treats ARS, since 2013.

    In 2017 the HSS partnered with Novartis, another pharmaceutical company, to determine if a product used for patients with low blood platelets, known as thrombocytopenia, could be used to protect people in the event of a nuclear incident.

    The supply of Nplate has been procured “to save lives following radiological and nuclear emergencies”, according to the HSS announcement.

    “ARS, also known as radiation sickness, occurs when a person’s entire body is exposed to a high dose of penetrating radiation, reaching internal organs in a matter of seconds,” it said. “Symptoms of ARS injuries include impaired blood clotting as a result of low platelet counts, which can lead to uncontrolled and life-threatening bleeding.

    “To reduce radiation-induced bleeding, Nplate stimulates the body’s production of platelets. The drug can be used to treat adults and children.”

    The Telegraph understands Nplate is approved for use in Europe and the UK to treat low blood platelet counts in adults, but there is currently no licence to use it for other purposes such as blood injuries following ARS. READ MORE

    United States Stocks Up On Radiation Drug Nplate As Putin Threatens Nuclear War

    The United States is upping its efforts to protect its citizens from the impact of any radiological and nuclear emergencies. The US health department is purchasing a drug that treats blood cell injuries caused due to acute radiation syndrome in adults and pediatric patients.

    Read More @ NowTheEndBegins.com